(E)-3-[4-({1-[(3-Cyclopentyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carbonyl)amino]cyclobutanecarbonyl}amino)phenyl]-acrylic Acid

ID: ALA2181776

Cas Number: 494856-61-0

PubChem CID: 56949326

Max Phase: Phase

Molecular Formula: C34H34N4O4

Molecular Weight: 562.67

Molecule Type: Small molecule

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Synonyms: BILB 1941 | Bilb-1941 | BILB-1941ZW | BILB 1941|BILB-1941|494856-61-0|UNII-3WV68DY85W|BILB1941|3WV68DY85W|BILB-1941ZW|CHEMBL2181776|BDBM50398052|AKOS040747979|HY-18079|CS-0007224|Q27258151|(2E)-3-(4-(((1-(((3-CYCLOPENTYL-1-METHYL-2-(2-PYRIDINYL)-1H-INDOL-6-YL)CARBONYL)AMINO)CYCLOBUTYL)CARBONYL)AMINO)PHENYL)-2-PROPENOIC ACID|2-PROPENOIC ACID, 3-(4-(((1-(((3-CYCLOPENTYL-1-METHYL-2-(2-PYRIDINYL)-1H-INDOL-6-YL)CARBONYL)AMINO)CYCLOBUTYL)CARBONYL)AMINO)PHENYL)-, (2E)-|N-(1-(((4-((E)-2-(CARBOXY)ETHENYLShow More

Canonical SMILES:  Cn1c(-c2ccccn2)c(C2CCCC2)c2ccc(C(=O)NC3(C(=O)Nc4ccc(/C=C/C(=O)O)cc4)CCC3)cc21

Standard InChI:  InChI=1S/C34H34N4O4/c1-38-28-21-24(13-16-26(28)30(23-7-2-3-8-23)31(38)27-9-4-5-20-35-27)32(41)37-34(18-6-19-34)33(42)36-25-14-10-22(11-15-25)12-17-29(39)40/h4-5,9-17,20-21,23H,2-3,6-8,18-19H2,1H3,(H,36,42)(H,37,41)(H,39,40)/b17-12+

Standard InChI Key:  JBSNALXXNTWUEC-SFQUDFHCSA-N

Molfile:  

     RDKit          2D

 42 47  0  0  0  0  0  0  0  0999 V2000
   41.6189   -1.9395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   42.2022   -1.3520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.6147   -0.7686    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   41.0314   -1.3561    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9632   -2.7628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7839   -2.7632    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2678   -3.4315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2700   -2.0966    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   37.0163   -1.3115    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0542   -2.3527    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0495   -3.1774    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7604   -3.5922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4764   -3.1832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4772   -2.3552    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7657   -1.9442    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0153   -4.2186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2305   -4.4729    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.2298   -5.2979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.0143   -5.5536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.4997   -4.8864    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1919   -1.9432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.9062   -2.3561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   40.1924   -1.1181    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   42.3352   -2.3569    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.0499   -1.9449    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   42.3347   -3.1820    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   43.7642   -2.3578    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   43.7616   -3.1804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4751   -3.5933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1908   -3.1812    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.1886   -2.3518    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   44.4746   -1.9427    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   45.9056   -3.5932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   46.6198   -3.1801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   47.3346   -3.5921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   48.0488   -3.1791    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   47.3352   -4.4171    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   35.5541   -2.0502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7342   -2.0495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3227   -2.7606    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.7372   -3.4739    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5556   -3.4711    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  1  1  0
  6  7  2  0
  7 11  1  0
 10  8  1  0
  8  6  1  0
  5  6  1  0
  8  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  1  0
 20 16  1  0
  7 16  1  0
 14 21  1  0
 21 22  1  0
 21 23  2  0
 22  1  1  0
  1 24  1  0
 24 25  1  0
 24 26  2  0
 25 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 31  1  0
 31 32  2  0
 32 27  1  0
 30 33  1  0
 33 34  2  0
 34 35  1  0
 35 36  1  0
 35 37  2  0
  5 38  2  0
 38 39  1  0
 39 40  2  0
 40 41  1  0
 41 42  2  0
 42  5  1  0
M  END

Alternative Forms

  1. Parent:

    ALA2181776

    BILB-1941

Associated Targets(Human)

CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C19 Tchem Cytochrome P450 2C19 (29246 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Caco-2 (12174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (16955 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP1A2 Tchem Cytochrome P450 1A2 (26471 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MAOA Tclin Monoamine oxidase A (11911 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NR3C1 Tclin Glucocorticoid receptor (14987 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGS2 Tclin Cyclooxygenase-2 (13999 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CTSG Tchem Cathepsin G (2304 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ALOX5 Tclin Arachidonate 5-lipoxygenase (6568 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GABRA1 Tclin GABA-A receptor; agonist GABA site (140 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADRA2A Tclin Alpha-2a adrenergic receptor (9450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Rhesus monkey (3147 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Canis familiaris (36305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Hepatitis C virus (23859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Liver microsomes (8692 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: YesAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 562.67Molecular Weight (Monoisotopic): 562.2580AlogP: 6.29#Rotatable Bonds: 8
Polar Surface Area: 113.32Molecular Species: ACIDHBA: 5HBD: 3
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.48CX Basic pKa: 4.09CX LogP: 5.31CX LogD: 2.69
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.22Np Likeness Score: -0.64

References

1. Beaulieu PL, Bös M, Cordingley MG, Chabot C, Fazal G, Garneau M, Gillard JR, Jolicoeur E, LaPlante S, McKercher G, Poirier M, Poupart MA, Tsantrizos YS, Duan J, Kukolj G..  (2012)  Discovery of the first thumb pocket 1 NS5B polymerase inhibitor (BILB 1941) with demonstrated antiviral activity in patients chronically infected with genotype 1 hepatitis C virus (HCV).,  55  (17): [PMID:22849725] [10.1021/jm3006788]
2. Beaulieu PL, Anderson PC, Bethell R, Bös M, Bousquet Y, Brochu C, Cordingley MG, Fazal G, Garneau M, Gillard JR, Kawai S, Marquis M, McKercher G, Poupart MA, Stammers T, Thavonekham B, Wernic D, Duan J, Kukolj G..  (2014)  Discovery of BI 207524, an indole diamide NS5B thumb pocket 1 inhibitor with improved potency for the potential treatment of chronic hepatitis C virus infection.,  57  (23): [PMID:25393851] [10.1021/jm501532z]
3. Beaulieu PL, Bolger G, Deon D, Duplessis M, Fazal G, Gagnon A, Garneau M, LaPlante S, Stammers T, Kukolj G, Duan J..  (2015)  Multi-parameter optimization of aza-follow-ups to BI 207524, a thumb pocket 1 HCV NS5B polymerase inhibitor. Part 2: Impact of lipophilicity on promiscuity and in vivo toxicity.,  25  (5): [PMID:25599836] [10.1016/j.bmcl.2014.12.078]
4. Unpublished dataset, 
5. Ganta NM, Gedda G, Rathnakar B, Satyanarayana M, Yamajala B, Ahsan MJ, Jadav SS, Balaraju T..  (2019)  A review on HCV inhibitors: Significance of non-structural polyproteins.,  164  [PMID:30639895] [10.1016/j.ejmech.2018.12.045]
6. Zhou Z, Zhang J, Zhou E, Ren C, Wang J, Wang Y..  (2022)  Small molecule NS5B RdRp non-nucleoside inhibitors for the treatment of HCV infection: A medicinal chemistry perspective.,  240  [PMID:35868125] [10.1016/j.ejmech.2022.114595]